News

As per the agreement, BioMarin will pay LEAD $18m upfront and will pay an additional $11m upon acceptance of the IND filing (filing expected by the end of

The injection is indicated for the treatment of iron deficiency anemia in adult patients with chronic kidney disease. Feraheme is contraindicated in patients with evidence of iron overload,

Voclosporin, a calcineurin inhibitor, is proposed for the treatment of non-infectious uveitis, involving the posterior segment of the eye. Its the leading cause of vision loss and long-term

Reportedly, Alpha1-Proteinase Inhibitor (Human, A1PI) will be an aerosol formulation. Talecris has also received an orphan drug designation for the aerosolized form of AAT from the European Commission

As per the agreement, Tecan will industrialise and deliver manufactured ML instruments for Enigma’s global market supplies for an initial five-year contract, and will also manage the ML

Gorbec currently provides complete development, regulatory, analytical, and manufacturing services for US-based customers. The company’s future plans call for an increased capacity to develop and submit New Drug

Together with many other pharmaceutical manufacturers, Teva is named in numerous civil lawsuits that relate to drug price reporting by manufacturers in about 15 states. The cases, which

The clinical candidate is a new class of agent containing three separate RNAi elements, simultaneously targeting three different sites of the hepatitis C virus, and encapsidated in an

Earlier, on April 16, 2008, Pfizer and Celldex Therapeutics (Celldex) have entered into an agreement to grant Pfizer an exclusive worldwide license to PF-04948568 (CDX-110) which is currently